HOUSTON, TX, Oct. 04, 2019 (GLOBE NEWSWIRE) — American International Holdings Corp. (OTC: “AMIH” or the “Company”) is pleased to announce that its newly launched subsidiary, YS Brands, Inc., has received its first purchase order from a major multi-billion-dollar ecommerce retailer for an initial purchase of 20,000 pairs of premium designer women’s shoes under the […]
Category Archives: Public Companies
Clear Blue Technologies and NuRAN Wireless to roll out Mobile Infrastructure at 50 Locations in the Marshall Islands
TORONTO, Oct. 04, 2019 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (Clear Blue or the “Company”) (TSXV: CBLU) (FRANKFURT: 0YA), the Smart Off-Grid company in clean managed wireless power, today announced an agreement with NuRAN Wireless (CNSX: NUR.CN) for 50 Smart Off-Grid power systems that will support the installation of enhanced mobile connectivity services […]
Husky Energy Announces Agreement to Sell Prince George Refinery
CALGARY, Alberta, Oct. 04, 2019 (GLOBE NEWSWIRE) — Husky Energy (TSX:HSE) today announced it has reached an agreement for the sale of its Prince George Refinery to Tidewater Midstream and Infrastructure for $215 million in cash plus a closing adjustment for inventory, and a contingent payment of up to $60 million over two years. Husky previously […]
Sarepta Therapeutics Announces Positive Functional Results from the SRP-9003 (MYO-101) Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
— Improvements on functional measures seen in all three participants — — Significant reduction in creatine kinase maintained over nine months — — Results follow positive and robust expression and biomarker data presented earlier in 2019 — CAMBRIDGE, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine […]
Capitala Finance Corp. Schedules Third Quarter 2019 Earnings Release and Conference Call
CHARLOTTE, N.C., Oct. 04, 2019 (GLOBE NEWSWIRE) — Capitala Finance Corp. (Nasdaq:CPTA) (the “Company”) announced today that it will report its third quarter 2019 financial results on Monday, November 4, 2019 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results at 8:30 a.m. EDT […]
Conformis Announces Departure of Paul Weiner, CFO
BILLERICA, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient’s unique anatomy, announced today that Paul Weiner, Chief Financial Officer, has notified the Company that he will be […]
Investview (OTCQB:INVU) Reports Initial APEX Sales Exceed Expectations
Eatontown, N.J., Oct. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Investview Inc. (OTCQB: INVU) through its wholly owned subsidiary APEX TEK LLC, reports sales in excess of company outlook and expectations. APEX TEK LLC, a wholly owned subsidiary of Investview, broad launched the APEX program on Saturday August 31st, 2019 with sales commencing September […]
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Camelina Platform for Producing PHB Biomaterials to Improve Water Quality at International Scientific Conference
WOBURN, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that Kristi Snell, Ph.D., Yield10’s Chief Science Officer, will present at the 3rd International Conference on Plant Synthetic Biology, Bioengineering […]
Westhaven Closes First Tranche of Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) — Westhaven Ventures Inc. (TSX-V:WHN) is pleased to announce that it has closed the first tranche of its non-brokered private placement previously announced on September 17th, 2019. This tranche raised gross […]
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
NEW YORK, Oct. 04, 2019 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of patients with rare neurological diseases, today announced the pricing of two concurrent but separate underwritten public offerings (together, the “Offerings”) of (i) 9,000,000 shares of its common stock and (ii) […]